vs

Side-by-side financial comparison of LSI INDUSTRIES INC (LYTS) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

LSI INDUSTRIES INC is the larger business by last-quarter revenue ($143.9M vs $83.1M, roughly 1.7× PROCEPT BioRobotics Corp). LSI INDUSTRIES INC runs the higher net margin — 1.4% vs -38.1%, a 39.4% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -4.4%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 2.1%).

LSI Logic Corporation was an American ASIC and EDA company founded in Santa Clara, California. The company designed and sold semiconductors and software that accelerated storage and networking in data centers, mobile networks and client computing.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

LYTS vs PRCT — Head-to-Head

Bigger by revenue
LYTS
LYTS
1.7× larger
LYTS
$143.9M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+24.6% gap
PRCT
20.2%
-4.4%
LYTS
Higher net margin
LYTS
LYTS
39.4% more per $
LYTS
1.4%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
2.1%
LYTS

Income Statement — Q1 FY2027 vs Q1 FY2026

Metric
LYTS
LYTS
PRCT
PRCT
Revenue
$143.9M
$83.1M
Net Profit
$2.0M
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
1.4%
-38.1%
Revenue YoY
-4.4%
20.2%
Net Profit YoY
-4.8%
-27.9%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LYTS
LYTS
PRCT
PRCT
Q3 26
$143.9M
Q1 26
$143.9M
$83.1M
Q4 25
$147.0M
$76.4M
Q3 25
$157.2M
$83.3M
Q2 25
$155.1M
$79.2M
Q1 25
$132.5M
$69.2M
Q4 24
$147.7M
$68.2M
Q3 24
$138.1M
$58.4M
Net Profit
LYTS
LYTS
PRCT
PRCT
Q3 26
$2.0M
Q1 26
$2.0M
$-31.6M
Q4 25
$6.3M
$-29.8M
Q3 25
$7.3M
$-21.4M
Q2 25
$8.2M
$-19.6M
Q1 25
$3.9M
$-24.7M
Q4 24
$5.6M
$-18.9M
Q3 24
$6.7M
$-21.0M
Gross Margin
LYTS
LYTS
PRCT
PRCT
Q3 26
Q1 26
64.9%
Q4 25
25.5%
60.6%
Q3 25
25.6%
64.8%
Q2 25
26.1%
65.4%
Q1 25
24.8%
63.9%
Q4 24
23.6%
64.0%
Q3 24
24.4%
63.2%
Operating Margin
LYTS
LYTS
PRCT
PRCT
Q3 26
Q1 26
-4.1%
Q4 25
6.0%
-40.6%
Q3 25
7.0%
-27.8%
Q2 25
7.7%
-28.0%
Q1 25
4.7%
-39.7%
Q4 24
5.7%
-28.9%
Q3 24
6.6%
-38.4%
Net Margin
LYTS
LYTS
PRCT
PRCT
Q3 26
1.4%
Q1 26
1.4%
-38.1%
Q4 25
4.3%
-39.1%
Q3 25
4.6%
-25.7%
Q2 25
5.3%
-24.7%
Q1 25
2.9%
-35.8%
Q4 24
3.8%
-27.6%
Q3 24
4.8%
-35.9%
EPS (diluted)
LYTS
LYTS
PRCT
PRCT
Q3 26
Q1 26
$-0.56
Q4 25
$0.20
$-0.54
Q3 25
$0.23
$-0.38
Q2 25
$0.26
$-0.35
Q1 25
$0.13
$-0.45
Q4 24
$0.18
$-0.34
Q3 24
$0.22
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LYTS
LYTS
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$261.0M
$51.7M
Stockholders' EquityBook value
$352.8M
$347.7M
Total Assets
$800.5M
$487.1M
Debt / EquityLower = less leverage
0.74×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LYTS
LYTS
PRCT
PRCT
Q3 26
Q1 26
$245.6M
Q4 25
$6.4M
$286.5M
Q3 25
$7.1M
$294.3M
Q2 25
$3.5M
$302.7M
Q1 25
$4.3M
$316.2M
Q4 24
$4.7M
$333.7M
Q3 24
$7.0M
$196.8M
Total Debt
LYTS
LYTS
PRCT
PRCT
Q3 26
$261.0M
Q1 26
$261.0M
$51.7M
Q4 25
$27.9M
$51.6M
Q3 25
$50.7M
$51.6M
Q2 25
$48.6M
$51.5M
Q1 25
$55.4M
$51.5M
Q4 24
$38.2M
$51.5M
Q3 24
$47.7M
$51.4M
Stockholders' Equity
LYTS
LYTS
PRCT
PRCT
Q3 26
$352.8M
Q1 26
$352.8M
$347.7M
Q4 25
$248.1M
$365.9M
Q3 25
$241.3M
$380.3M
Q2 25
$230.7M
$385.8M
Q1 25
$221.7M
$389.2M
Q4 24
$217.1M
$402.2M
Q3 24
$211.2M
$241.2M
Total Assets
LYTS
LYTS
PRCT
PRCT
Q3 26
$800.5M
Q1 26
$800.5M
$487.1M
Q4 25
$396.3M
$508.1M
Q3 25
$404.9M
$511.5M
Q2 25
$396.4M
$513.1M
Q1 25
$384.6M
$519.4M
Q4 24
$344.5M
$534.0M
Q3 24
$349.5M
$374.1M
Debt / Equity
LYTS
LYTS
PRCT
PRCT
Q3 26
0.74×
Q1 26
0.74×
0.15×
Q4 25
0.11×
0.14×
Q3 25
0.21×
0.14×
Q2 25
0.21×
0.13×
Q1 25
0.25×
0.13×
Q4 24
0.18×
0.13×
Q3 24
0.23×
0.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LYTS
LYTS

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons